Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Oct
5
2019
New Connecticut Law Requires Policy on Opioid Antagonists at Colleges, Universities Jackson Lewis P.C.
Oct
4
2019
McDermottPlus Check-up: October 4, 2019 McDermott Will & Emery
Oct
4
2019
District of Oregon Holds that Vineyard’s RICO Suit Against Neighboring Marijuana Grower is More than just Sour Grapes Bilzin Sumberg
Oct
4
2019
USDA Set to Unveil New Rule Combating Fraudulently Labeled “Organic” Products Keller and Heckman LLP
Oct
4
2019
Mayo Clinic Reports Vaping Injuries Resemble Chemical Burns Stark & Stark
Oct
4
2019
DBO Issues Guidance To Banks And Credit Unions Serving Cannabis Related Businesses Allen Matkins Leck Gamble Mallory & Natsis LLP
Oct
4
2019
FDA Announces Availability Of Draft Guidance On Bioequivalency For Soluble Powder Oral Dosage Form Products And Type A Medicated Articles Bergeson & Campbell, P.C.
Oct
3
2019
Is Your Software a Medical Device? FDA Issues Six Digital Health Guidance Documents McDermott Will & Emery
Oct
3
2019
NIOSH Nanotechnology Research Center Seeks Input from Manufacturers, Distributors, Fabricators, Formulators, and Users of Engineered Nanomaterials Bergeson & Campbell, P.C.
Oct
3
2019
Third Circuit Holds that SLUSA Does Not Preclude Class Action Opt-Outs from Pursuing Individual Actions Sheppard, Mullin, Richter & Hampton LLP
Oct
3
2019
Privacy Tip #210 – HHS Office of Inspector General Issues Fraud Alert for Genetic Testing Scam Targeting Seniors Robinson & Cole LLP
Oct
3
2019
CDC Finds Decrease in Foodborne Disease Outbreaks from 2015 to 2017 Keller and Heckman LLP
Oct
3
2019
Let Them Eat Cake (If We Coordinate) – Will UK Government Waive Competition Rules in Response to Food/Drink Shortages? Squire Patton Boggs (US) LLP
Oct
3
2019
EPA Publishes TSCA SACC Meeting Minutes and Final Report on Draft Risk Evaluation for PV29 Bergeson & Campbell, P.C.
Oct
3
2019
No Right, Just Rules: Court Lacks Jurisdiction Over Steakhouse Managers’ Claims Barnes & Thornburg LLP
Oct
3
2019
FDA to Convene Metal-Containing Implants and Dental Amalgams Panel, Nov. 13-14, 2019 Dinsmore & Shohl LLP
Oct
3
2019
EPA Seeks Comment on its Draft Antimicrobial Performance Evaluation Program (APEP) Risk-Based Strategy for Products in the Marketplace with Public Health Claims Bergeson & Campbell, P.C.
Oct
2
2019
California Water Board Could Leave Non-Compliant Emerald Triangle Cannabis Farmers High & Dry Beveridge & Diamond PC
Oct
2
2019
Truly Organic? Not Really, Says FTC Keller and Heckman LLP
Oct
2
2019
Opioid Update: More Irons in the Fire Squire Patton Boggs (US) LLP
Oct
2
2019
Juul CEO says “Don’t vape. Don’t use Juul.” Stark & Stark
Oct
2
2019
SEC: Here Is When Loss Contingencies Must Be Disclosed and Reserved Faegre Drinker
Oct
2
2019
EPA Announces Revised Service Fees for Pesticide Registration Applications Under PRIA 4 Bergeson & Campbell, P.C.
Oct
2
2019
Public Comments Urge FDA to Allow “Potassium Salt” as Alternative Name for “Potassium Chloride” in Food Labeling Keller and Heckman LLP
Oct
1
2019
FDA Launches Dashboard to Track FSMA Progress Keller and Heckman LLP
Sep
30
2019
CBD Industry Beware: The False Labeling Class Action Has Arrived Sheppard, Mullin, Richter & Hampton LLP
Sep
30
2019
New Set Of Guidance From FDA Provides Clarity On Digital Health Policies, Machine Learning Sheppard, Mullin, Richter & Hampton LLP
Sep
30
2019
EPA Releases Final Test Guidelines for Premises Treatments Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins